Department of Gastroenterology and Hepatology, Radboud University Medical Center, Radboud Institute of Health Sciences, Nijmegen, Netherlands.
Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, Netherlands.
Trials. 2021 Jan 18;22(1):63. doi: 10.1186/s13063-020-04996-7.
Endoscopic mucosal resection (EMR) for large colorectal polyps is in most cases the preferred treatment to prevent progression to colorectal carcinoma. The most common complication after EMR is delayed bleeding, occurring in 7% overall and in approximately 10% of polyps ≥ 2 cm in the proximal colon. Previous research has suggested that prophylactic clipping of the mucosal defect after EMR may reduce the incidence of delayed bleeding in polyps with a high bleeding risk.
The CLIPPER trial is a multicenter, parallel-group, single blinded, randomized controlled superiority study. A total of 356 patients undergoing EMR for large (≥ 2 cm) non-pedunculated polyps in the proximal colon will be included and randomized to the clip group or the control group. Prophylactic clipping will be performed in the intervention group to close the resection defect after the EMR with a distance of < 1 cm between the clips. Primary outcome is delayed bleeding within 30 days after EMR. Secondary outcomes are recurrent or residual polyps and clip artifacts during surveillance colonoscopy after 6 months, as well as cost-effectiveness of prophylactic clipping and severity of delayed bleeding.
The CLIPPER trial is a pragmatic study performed in the Netherlands and is powered to determine the real-time efficacy and cost-effectiveness of prophylactic clipping after EMR of proximal colon polyps ≥ 2 cm in the Netherlands. This study will also generate new data on the achievability of complete closure and the effects of clip placement on scar surveillance after EMR, in order to further promote the debate on the role of prophylactic clipping in everyday clinical practice.
ClinicalTrials.gov NCT03309683 . Registered on 13 October 2017. Start recruitment: 05 March 2018. Planned completion of recruitment: 31 August 2021.
内镜黏膜切除术(EMR)是治疗大肠较大息肉的首选方法,可预防其进展为结直肠癌。EMR 后最常见的并发症是延迟性出血,总体发生率为 7%,在近端大肠直径≥2cm 的息肉中约占 10%。既往研究表明,EMR 后对黏膜缺损进行预防性夹闭可能会降低高出血风险息肉延迟性出血的发生率。
CLIPPER 试验是一项多中心、平行组、单盲、随机对照优效性研究。共纳入 356 例行 EMR 治疗的近端大肠较大(≥2cm)无蒂息肉患者,将其随机分为夹闭组或对照组。干预组将在 EMR 后对切除缺损进行预防性夹闭,夹闭间距<1cm。主要结局是 EMR 后 30 天内延迟性出血。次要结局是 6 个月后随访结肠镜检查时的复发性或残留息肉和夹闭伪影,以及预防性夹闭的成本效益和延迟性出血的严重程度。
CLIPPER 试验是在荷兰进行的一项实用研究,旨在确定荷兰直径≥2cm 的近端大肠息肉 EMR 后预防性夹闭的实时疗效和成本效益。该研究还将提供关于完全闭合的可实现性以及夹闭放置对 EMR 后瘢痕监测影响的新数据,以进一步推动关于预防性夹闭在日常临床实践中作用的讨论。
ClinicalTrials.gov NCT03309683。于 2017 年 10 月 13 日注册。开始招募:2018 年 3 月 5 日。预计完成招募:2021 年 8 月 31 日。